What is vasovagal syncope, including its pathophysiology, clinical presentation, diagnostic evaluation, and management?

Vasovagal Syncope: Clinical Overview

Definition and Pathophysiology

Vasovagal syncope (VVS) is the most common form of reflex syncope, caused by a brain-mediated reflex that triggers inappropriate vasodilation and/or bradycardia, leading to transient loss of consciousness due to reduced cerebral blood flow. 1

The pathophysiological cascade begins with:

• Venous pooling causing decreased stroke volume 2
• Cardioinhibition (heart rate decrease) that accelerates blood pressure drop, representing the critical turning point 2
• Vasodepressor response with excessive blood vessel dilation, causing blood to pool in the lower body 1
• The brain may signal the heart to slow or temporarily stop (not a cardiac disease, but a healthy heart receiving incorrect autonomic signals) 1

Clinical Presentation

Typical (Classical) VVS

The diagnosis rests primarily on specific historical clues rather than testing. 1 Look for:

• Triggers: Pain, emotion, blood exposure, venipuncture, prolonged standing 1
• Prodromal symptoms: Nausea, diaphoresis, warmth, pallor, lightheadedness 1
• Event characteristics: Brief loss of consciousness (typically <1 minute), rapid recovery to full consciousness 1
• Post-event: Fatigue is common; children may fall asleep 1
• Associated features: Brief myoclonic jerks or incontinence may occur but do not indicate epilepsy 1

Atypical (Non-Classical) VVS

Atypical presentations are more common in older adults and include short or absent prodrome, amnesia for loss of consciousness, and can be misdiagnosed as falls. 3, 4

• Unexplained falls may represent VVS with retrograde amnesia, showing ~60% positivity on tilt testing 4
• Syncope during sleep may be VVS with high prevalence of autonomic prodromes and severe cardioinhibition 4
• Older patients typically lack the characteristic diaphoresis and nausea seen in younger patients 1

Diagnostic Evaluation

Initial Assessment

Diagnosis is made primarily through thorough history, physical examination, and ECG—not through extensive testing. 1

Key elements to assess:

• Orthostatic vital signs: Check for orthostatic hypotension (≥20 mmHg systolic or ≥10 mmHg diastolic drop within 3 minutes of standing) 1
• ECG: Rule out cardiac causes; structural heart disease makes VVS diagnosis less likely 3
• Medication review: Identify hypotension-inducing drugs and diuretics 5

Tilt Table Testing

Head-up tilt testing is used to provoke an attack when diagnosis is uncertain, not as a first-line test. 1, 6

• Drug-free protocols show 34% positivity in patients with syncope 6
• Nitroglycerin potentiation increases diagnostic yield to 62%, superior to isoproterenol (53%) 6
• Age matters: Younger patients show higher positivity rates; testing is more relevant in older patients when potentiated with nitroglycerin 6
• The test monitors blood pressure and heart rate during provoked syncope to confirm the diagnosis 1

Management

First-Line Conservative Measures

Most patients do well after specialist evaluation, reassurance, and education alone. 5

Lifestyle Modifications

• Hydration and salt intake: Adequate fluid intake and increased salt (when not contraindicated by hypertension or heart failure) 5, 7
• Medication adjustment: Carefully withdraw diuretics and hypotension-inducing drugs 5
• Trigger avoidance: Identify and avoid specific triggers identified in history 1

Physical Counterpressure Maneuvers

Leg crossing and hand grip maneuvers can abort prodromal symptoms but have limited efficacy in older patients and those with short/absent prodromes. 1, 5

Other Non-Pharmacological Approaches

• Orthostatic training: Lacks long-term efficacy and suffers from poor compliance 5
• Yoga: May be helpful, though mechanism unknown 5

Pharmacological Treatment

Nearly one-third of VVS patients continue fainting despite conservative measures and require medication. 5

Effective Medications

• Fludrocortisone: Significantly reduces syncope recurrences with tolerable side effects when titrated to target doses 5, 8
• Midodrine: Significantly reduces syncope recurrences with tolerable side effects when titrated to target doses 5, 8
• Serotonin-specific reuptake inhibitors (SSRIs): Two SSRIs have shown effectiveness 8
• Atomoxetine: Currently under investigation 8

Ineffective Medications

Metoprolol and beta-blockers should NOT be used—they were not helpful in pivotal randomized trials. 5, 8

Invasive Therapies

Pacing therapy and cardioneuroablation must be reserved for the rare patient who has not responded to conservative and pharmacological treatments. 5, 8

• Specialized pacemakers: Appear promising in carefully selected populations with refractory symptoms 5
• Cardioneuroablation: May be helpful but lacks formal clinical trial evidence 5

Prognosis and Quality of Life Impact

VVS is not associated with mortality but causes significant morbidity through injuries, reduced quality of life, anxiety, and depression. 5, 3

• Natural history: Usually characterized by improvement and remissions over time 8
• Injuries: Common but serious injuries are rare 8
• Quality of life: Significantly reduced, particularly with recurrent episodes, but improves with appropriate care 5, 8
• Long-term outlook: Almost all patients eventually stop fainting with ongoing support 8

Common Pitfalls

• Over-testing: Avoid extensive cardiac workup when history clearly suggests VVS and ECG is normal 1, 3
• Misdiagnosis in elderly: Atypical presentations without prodrome may be labeled as "falls" rather than syncope 3, 4
• Inappropriate beta-blocker use: Despite historical use, these are ineffective and should be avoided 5, 8
• Premature invasive therapy: Pacemakers and ablation should only be considered after failure of all conservative and pharmacological options 5, 8